A professional-use rapid COVID-19 antigen test with a 15-minute run time for clinical and professional settings. It enables healthcare providers to quickly diagnose COVID-19 infection and support rapid clinical decision-making. The test delivers point-of-care results for timely patient management.
Manufactured by
bioLytical Laboratories Inc.
Richmond, BC, Canada
Creating new testing opportunities. based in Richmond, BC, Canada, bioLytical® Laboratories Inc. is a privately held Canadian company founded in 2002. bioLytical empowers physicians and the public to make informed health decisions faster. Combining quality made in Canada with a global focus, bioLytical is a leader in the field of rapid in vitro medical diagnostics. The one-minute INSTI tests® provide immediate, accurate results for infectious diseases such as COVID-19, HIV, hepatitis C (HCV) and syphilis.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
SHENZHEN MAIDE BIOTECHNOLOGY CO.,LTD
China · 1 relevant product
Anbio Biotechnology Limited
Germany · 1 relevant product
JULI MEDICAL LIMITED
China · 3 relevant products
86 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →17 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 35 relevant matches
SHENZHEN MAIDE BIOTECHNOLOGY CO.,LTD · China
Point-of-care rapid antigen test for SARS-CoV-2 detection with results available within 15-20 minutes. Designed for clinical use in hospitals, clinics, and testing centers with high sensitivity and specificity.
Anbio Biotechnology Limited · Germany
Point-of-care immunoassay for rapid detection of COVID-19 antigens in clinical samples. Delivers results within 15-30 minutes for immediate clinical decision-making.
JULI MEDICAL LIMITED · China
Rapid antigen detection test for acute SARS-CoV-2 infection. Provides results within minutes for immediate clinical decision-making.
32 more relevant matches available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products